BMEA
Price
$1.10
Change
-$0.01 (-0.90%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
78.13M
61 days until earnings call
Intraday BUY SELL Signals
CAI
Price
$21.82
Change
-$1.38 (-5.95%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
6.55B
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMEA vs CAI

Header iconBMEA vs CAI Comparison
Open Charts BMEA vs CAIBanner chart's image
Biomea Fusion
Price$1.10
Change-$0.01 (-0.90%)
Volume$6.96K
Capitalization78.13M
Caris Life Sciences
Price$21.82
Change-$1.38 (-5.95%)
Volume$67.19K
Capitalization6.55B
BMEA vs CAI Comparison Chart in %
BMEA
Daily Signal:
Gain/Loss:
CAI
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BMEA vs. CAI commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Hold and CAI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (BMEA: $1.11 vs. CAI: $23.20)
Brand notoriety: BMEA and CAI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 61% vs. CAI: 115%
Market capitalization -- BMEA: $78.13M vs. CAI: $6.55B
BMEA [@Biotechnology] is valued at $78.13M. CAI’s [@Biotechnology] market capitalization is $6.55B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 0 FA rating(s) are green whileCAI’s FA Score has 1 green FA rating(s).

  • BMEA’s FA Score: 0 green, 5 red.
  • CAI’s FA Score: 1 green, 4 red.
According to our system of comparison, both BMEA and CAI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 2 TA indicator(s) are bullish while CAI’s TA Score has 4 bullish TA indicator(s).

  • BMEA’s TA Score: 2 bullish, 7 bearish.
  • CAI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CAI is a better buy in the short-term than BMEA.

Price Growth

BMEA (@Biotechnology) experienced а -14.62% price change this week, while CAI (@Biotechnology) price change was -10.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

BMEA is expected to report earnings on Apr 06, 2026.

CAI is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAI($6.55B) has a higher market cap than BMEA($78.1M). BMEA YTD gains are higher at: -10.484 vs. CAI (-14.010). BMEA (-97.83M) and CAI (-100.84M) have comparable annual earnings (EBITDA) . CAI has more cash in the bank: 755M vs. BMEA (46.6M). BMEA has less debt than CAI: BMEA (6.88M) vs CAI (427M). CAI has higher revenues than BMEA: CAI (649M) vs BMEA (0).
BMEACAIBMEA / CAI
Capitalization78.1M6.55B1%
EBITDA-97.83M-100.84M97%
Gain YTD-10.484-14.01075%
P/E RatioN/AN/A-
Revenue0649M-
Total Cash46.6M755M6%
Total Debt6.88M427M2%
FUNDAMENTALS RATINGS
CAI: Fundamental Ratings
CAI
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMEACAI
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
13%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 8 days ago
61%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 6 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BMEA
Daily Signal:
Gain/Loss:
CAI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AAASX13.410.21
+1.59%
DWS RREEF Real Assets S
JGYAX13.070.05
+0.38%
JHancock Global Shareholder Yield A
ABIYX20.800.05
+0.24%
AB International Value Advisor
RNPGX71.83-0.90
-1.24%
American Funds New Perspective R6
SGQCX42.29-0.60
-1.40%
DWS International Opportunities C

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with VYGR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then VYGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
+0.91%
VYGR - BMEA
38%
Loosely correlated
-2.25%
RCUS - BMEA
36%
Loosely correlated
+1.39%
TCRX - BMEA
36%
Loosely correlated
-2.37%
SYRE - BMEA
36%
Loosely correlated
+1.65%
IDYA - BMEA
36%
Loosely correlated
+0.50%
More

CAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAI has been loosely correlated with BMEA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CAI jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAI
1D Price
Change %
CAI100%
-0.51%
BMEA - CAI
35%
Loosely correlated
+0.91%
CRDF - CAI
28%
Poorly correlated
-1.75%
VTGN - CAI
23%
Poorly correlated
-6.19%
SNTI - CAI
21%
Poorly correlated
-2.97%
LIXT - CAI
20%
Poorly correlated
-5.06%
More